For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Taking a walk in Barb’s boots
Wednesday 31 July 2019, 07:15 AM

Behavioural health trainer and primary healthcare researcher Barbara Docherty at the Rotorua GP CME last month
New Zealand Doctor columnist and primary healthcare researcher Barbara Docherty went along to this year’s Rotorua GP CME with an eye out for what the nurses’ programme had to offer
Women giving birth later and sperm counts lower worldwide account for a new way of looking at conceiving
Do nurses need a separate nurses’ progra
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.